| Literature DB >> 27792922 |
Nisreen Salti1, Elizabeth Brouwer2, Stéphane Verguet3.
Abstract
Tobacco use is a significant risk factor for the leading causes of death worldwide, including cancer, heart disease and stroke. Most of these deaths occur in low- and middle-income countries, where tobacco-related deaths are also rising rapidly. Taxation is one of the most effective tobacco control measures, yet evidence on the distributional impact of tobacco taxation in low- and middle-income countries remains scant. This paper considers the financial and health effects, by socio-economic class, of increasing tobacco taxes in Lebanon, a middle-income country. An Almost Ideal Demand System is used to estimate price elasticities of demand for tobacco products. Extended cost-effectiveness analysis (ECEA) methods are applied to quantify, across quintiles of socio-economic status, the health benefits gained, the additional tax revenues raised, and the net financial consequences for households from a 50% increase in the price of tobacco through excise taxes. We find that demand for tobacco is price inelastic with elasticities ranging from -0.32 for the poorest quintile to -0.22 for the richest quintile. The increase in tobacco tax is estimated to result in 65,000 (95% CI: 37,000-93,000) premature deaths averted, 25% of them in the poorest quintile, $300M ($256-340M) of additional tax revenues, 12% borne by the poorest quintile, $23M ($13-33M) of out-of-pocket spending on healthcare averted, 36% of which accrue to the poorest quintile, 9% to the richest. These savings would be associated with 23,000 (13,000-33,000) poverty cases averted (63% in the poorest quintile). Increasing tobacco taxes would lead to large financial and health benefits, and would be pro-poor in health gains, savings on healthcare, and poverty reduction.Entities:
Keywords: Distributional consequences; Equity; Extended cost-effectiveness analysis; Financial risk protection; Lebanon; Tobacco taxation
Mesh:
Year: 2016 PMID: 27792922 PMCID: PMC5115647 DOI: 10.1016/j.socscimed.2016.10.020
Source DB: PubMed Journal: Soc Sci Med ISSN: 0277-9536 Impact factor: 4.634
Inputs used for the modeling of the increase in tobacco excise tax in Lebanon.
| Input | Values | Data sources | |||
|---|---|---|---|---|---|
| Smoking prevalence by age (%) | Male | Female | GYTS | ||
| Under 15 | 18 | 6 | |||
| 15–19 | 27 | 13 | |||
| 20–24 | 38 | 19 | |||
| 25–34 | 41 | 18 | |||
| 35–44 | 49 | 33 | |||
| 45–54 | 55 | 46 | |||
| 55–64 | 46 | 45 | |||
| 65–69 | 29 | 21 | |||
| 70–74 | 31 | 33 | |||
| 75–79 | 25 | 24 | |||
| 80–84 | 18 | 19 | |||
| 85+ | 18 | 19 | |||
| Quintile annual household expenditures (2012 USD) per adult equivalent and smoking prevalence rates | Expenditures | Prevalence | Household living conditions survey (2005), inflation (World Development Indicators), National Household Health Expenditures and Use Survey (NHHEUS) 1999 (data for 1996) | ||
| Q1 | $1604 | 28 | |||
| Q2 | $2589 | 28 | |||
| Q3 | $3557 | 27 | |||
| Q4 | $4943 | 25 | |||
| Q5 | $9329 | 22 | |||
| Imported cigarettes (in millions of 2012 USD) | 339 | Customs data, 2012 | |||
| Expenditures on imported cigarettes by quintile (millions of 2012 USD) | Q1 | 104 | Authors' calculations based on: data on total value of imported cigarettes in 2012 (customs data); share of each quintile in spending by product calculated using 2005 household survey data ( | ||
| Q2 | 151 | ||||
| Q3 | 163 | ||||
| Q4 | 180 | ||||
| Q5 | 196 | ||||
| Total | 794 | ||||
| Price of imported cigarettes (per pack, 2012 USD) | $2.15 | ||||
| Share of tax in price, imported cigarettes | 47% | Authors' calculations based on Ministry of Finance data ( | |||
| Distribution of tobacco-related disease mortality, by cause (%) | COPD | 6% | Global Burden of Disease study ( | ||
| Lung cancer | 13% | ||||
| Stroke | 19% | ||||
| Ischemic heart disease | 55% | ||||
| Hypertensive heart disease | 3% | ||||
| Bladder cancer | 3% | ||||
| Reduction in mortality risk by age at quitting smoking | 15–24 | 98% | |||
| 25–44 | 85% | ||||
| 45–64 | 75% | ||||
| 65+ | 25% | ||||
| Utilization rates of healthcare services by tobacco-related disease | Hypertensive | 21% | Authors' calculations (detailed in the data | ||
| Ischemic | 43% | ||||
| Cerebrovascular | 29% | ||||
| Respiratory neoplasms | 49% | ||||
| Urinary neoplasms | 7% | ||||
| Respiratory | 26% | ||||
| Utilization rates of healthcare services conditional on reporting a health problem (standardized to use Quintile 3 as a reference) | Q1 | 0.95 | Authors' calculations based on NHHEUS 1996 | ||
| Q2 | 0.95 | ||||
| Q3 | 1 | ||||
| Q4 | 1.01 | ||||
| Q5 | 1.08 | ||||
| Hospitalization cost by tobacco-related disease (2012 USD) | COPD | $951 | National Social Security Fund (NSSF) data in | ||
| Lung cancer | $2227 | ||||
| Stroke | $951 | ||||
| Ischemic | $1466 | ||||
| Hypertensive | $1466 | ||||
| Bladder cancer | $2227 | ||||
| Fraction of healthcare costs paid out-of-pocket by quintile | Q1 | 83% | Coverage rates from | ||
| Q2 | 70% | ||||
| Q3 | 60% | ||||
| Q4 | 49% | ||||
| Q5 | 35% | ||||
| Poverty line of expenditures (2012 USD) per person per day | $4 | ||||
| Poverty rate | 29% | ||||
COPD, chronic obstructive pulmonary disease.
The impact of a 50% increase in the price of imported cigarettes on health, spending and tax revenues (95% confidence interval).
| Q1 (poorest) | Q2 | Q3 | Q4 | Q5 (richest) | Total | |
|---|---|---|---|---|---|---|
| Premature deaths averted | 17,000 (9400–24,600) | 14,400 (9000–19,000) | 13,300 (6100–21,000) | 11,000 (6500–16,000) | 9000 (6000–13,000) | 65,000 (37,000–93,000) |
| Additional excise tax revenues in millions of USD | 36 (28–43) | 56 (49–63) | 60 (50–72) | 69 (60–78) | 77 (69–85) | 300 (256–341) |
| % of total borne by quintile | 12.0% | 18.6% | 20.4% | 23.1% | 25.8% | |
| % of household expenditures/adult equivalent | 2.8% | 2.7% | 2.1% | 1.7% | 1.0% | 1.7% |
| Change in expenditures on tobacco products (in millions of USD) | 27 (15–38) | 45 (35–56) | 50 (33–67) | 58 (44–71) | 66 (52–77) | 245 (179–310) |
| % of household expenditures/adult equivalent | 2.1% (1.2%–2.9%) | 2.1% (1.7%–2.7%) | 1.7% (1.1%–2.3%) | 1.4% (1.1%–1.8%) | 0.9% (0.7%–1.0%) | 1.4% (1.0%–1.7%) |
| Expenditures on tobacco-related disease treatment averted (in millions of USD) | 9 (5–13) | 8 (5–10) | 8 (4–12) | 6 (4–8) | 5 (4–8) | 37 (21–53) |
| Out-of-pocket expenditures averted by households (in millions of USD) | 8 (4–11) | 5 (3–7) | 4 (2–7) | 3 (2–4) | 2 (1–3) | 22 (13–33) |
| % of all savings accruing to Q | 36% | 23% | 18% | 14% | 9% | |
| % of household expenditures/adult equivalent | 0.60% (0.30–0.86%) | 0.20% (0.16–0.35%) | 0.10% (0.07–0.24%) | 0.07% (0.05–0.11%) | 0.02% (0.01–0.04%) | 0.10% (0.07–0.18%) |
| Poverty cases averted | 17,000 (9400–24,600) | 9800 (3600–7600) | 0 | 0 | 0 | 26,800 (13,000–32,200) |
| Fraction of Q moving out of poverty | 2.0% | 1.2% | – | – | – | – |
Fig. 1Share of expenditures on imported cigarettes in total household expenditures by quintile for different price changes.
Results from application of the Almost Ideal Demand System (AIDS) model.
| Price elasticity of demand for imported tobacco by income quintile (95% confidence interval) | ||
|---|---|---|
| Q1 (poorest) | −0.32 | (−0.47 −0.18) |
| Q2 | −0.27 | (−0.36 −0.17) |
| Q3 | −0.26 | (−0.40 −0.12) |
| Q4 | −0.24 | (−0.34 −0.14) |
| Q5 (richest) | −0.22 | (−0.31 −0.14) |